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Edited by Ulf-Ingo Flu¨ggeAbstract Chloroplasts of higher plants contain a unique signal
recognition particle (cpSRP) that consists of two proteins,
cpSRP54 and cpSRP43. CpSRP43 is composed of a four anky-
rin repeat domain and three functionally distinct chromodomains
(CDs). In this report we conﬁrm previously published data that
the second chromodomain (CD2) provides the primary binding
site for cpSRP54. However, quantitative binding analysis dem-
onstrates that cpSRP54 binds to CD2 signiﬁcantly less eﬃ-
ciently than it binds to full-length cpSRP43. Further analysis
of the binding interface of cpSRP by mutagenesis studies and
a pepscan approach demonstrates that the C-terminal a-helix
of CD2 facilitates binding to cpSRP54.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The light-harvesting chlorophyll a/b-binding proteins
(LHCPs) constitute the antenna system of the photosynthetic
apparatus and comprise approximately one third of the thy-
lakoid membrane proteins. The nuclear encoded LHCPs are
ﬁrst imported into the chloroplast and then directed to the
thylakoid membrane via the chloroplast signal recognition
particle (cpSRP) pathway (reviewed in: [1,2]). During the
transport through the stroma, LHCP is bound by cpSRP
to form the transit complex, a soluble targeting intermediate
of LHCP [3,4]. CpSRP consists of two protein subunits of 54
and 43 kDa (cpSRP54 and cpSRP43). In contrast to all
known cytosolic SRPs, chloroplast SRP does not contain
an RNA component. CpSRP54 is composed of an N-termi-
nal NG-domain encoding a GTPase function and a C-termi-
nal M-domain (cpSRP54M). Recently, it was shown that a
10 amino acid long segment located close to the C-terminusAbbreviations: cpSRP, chloroplast signal recognition particle; CD,
chromodomain; LHCP, light-harvesting chlorophyll a/b-binding
proteins; SPR, surface plasmon resonance
*Corresponding author. Fax: +49 234 3214184.
E-mail address: Danja.Schuenemann@rub.de (D. Schu¨nemann).
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.04.055of cpSRP54 is crucial for cpSRP complex formation, since it
forms the cpSRP43-binding site [5]. The cpSRP43 subunit is
characterized by the presence of four ankyrin repeats and
three chromodomains (CDs) [6–8] (Fig. 1). Ankyrin repeat
domains are present in a large number of eukaryotic and
prokaryotic proteins, and form the binding sites for a large
variety of interacting partners (reviewed in: [9,10]). The
ankyrin repeat domain of cpSRP43 has been shown to be in-
volved in binding LHCP in the transit complex [7]. CDs
(chromatin organization modiﬁer) are highly conserved struc-
tural motifs found in nuclear proteins that are involved in
regulating the chromatin structure. Functional analysis has
shown that CDs mediate the binding to a large variety of
binding targets (proteins and nucleic acids) by a remarkable
diversity of interaction modes [reviewed in: 11,12]. In
cpSRP43, CD1 has been shown to be important for LHCP
integration by regulating the GTPase cycle of cpSRP54
and its receptor cpFtsY [8]. CD2 and CD3 were described
to provide the binding interface for cpSRP54 [7]. However,
other data show that CD2 alone mediates binding to
cpSRP54 [8,13]. Recently, the three-dimensional structures
of the CDs of cpSRP43 were solved by NMR techniques
[13]. CD2 and CD3 are composed of a triple-stranded anti-
parallel b-sheet and a C-terminal helix, structural elements
that are typically found in classical CDs. Interestingly,
CD2 diﬀers signiﬁcantly from CD3 in the orientation of
the C-terminal helix. The a-helix in CD2 is positioned per-
pendicular to the plane of the b-sheet, whereas the a-helix
in CD3 is parallel to the plane of the b-sheet. The structure
of CD1 also contains a triple-stranded antiparallel b-sheet
but lacks the C-terminal helix.
In this study we have applied surface plasmon resonance
(SPR) experiments to quantitate the binding between
cpSRP54 and full-length cpSRP43 or various cpSRP43 trun-
cation constructs. We conﬁrmed the previously published
observation of Goforth et al. [8] and Sivaraja et al. [13] that
CD2 alone is able to bind cpSRP54. However, the binding
aﬃnity was signiﬁcantly lower than using full-length
cpSRP43. To determine which speciﬁc CD2 structural ele-
ments enable its binding to cpSRP54, we analysed the molec-
ular details of this interaction using in vivo and in vitro
binding experiments in combination with a pepscan ap-
proach. We show that the C-terminal a-helix of CD2 is cru-
cial for cpSRP complex formation since it mediates binding
of cpSRP54.blished by Elsevier B.V. All rights reserved.
Fig. 1. Domain organization of cpSRP43 and structural details of CD2 and CD3. (A) cpSRP43 is composed of three CDs (dark boxes) and four
ankyrin repeats (grey boxes) [6–8]. (B) The structure of CD2 and CD3 (CD2: residues 270–321; CD3: 322–372) is characterized by the presence of
three b-strands and a C-terminal a-helix as determined by NMR analysis [13]. Negatively charged residues in CD2 are underlined. The numbers refer
to the amino acid position and are based on the precursor polypeptide that is predicted to contain a 60-residue chloroplast targeting sequence.
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2.1. Plasmids
The cDNAs encoding cpSRP43(255–376), cpSRP43(227–376) and
cpSRP43(227–320) were ampliﬁed from full-length cpSRP43-cDNA
using gene speciﬁc primers with unique restriction sites (BamHI/XhoI).
The corresponding cDNAs were cloned into the BamHI/XhoI site of
the expression vector pGEX-4T-3.
All of the site-directed mutagenesis constructs were generated
using the QuikChange XL site-directed mutagenesis kit (Stratagene)
according to the manufacturer’s protocol. The plasmids pACT2-
cpSRP43 or pGex-4T-3-cpSRP43 were used as templates to gain
the single or double point mutation constructs for yeast two-hybrid
experiments or the constructs encoding mutated GST-cpSRP43,
respectively. The correct sequence of the constructs was veriﬁed by
sequencing (Seqlab).
All other plasmids used in this study have been described previously
and are listed as follows: GST-cpSRP43 expression vector (pGex4Tch-
aos(m) [4], cpSRP54M-his and cpSRP54M(D536–540)-his expression
vector (constructs cloned in pET29b) [5], yeast two-hybrid vectors
pACT2-43 and pGBKT7-54M [5,7], cpSRP54M and Lhcb1 translation
vectors (pGem4SS6.5-54M and pAB80) [5,14].
2.2. Protein overexpression and puriﬁcation
Recombinant cpSRP54M-his or cpSRP54M(D536–540)-his were ex-
pressed from their corresponding pET29b(+) constructs in the E. coli
strain BL21 (DE3) pLysS (Invitrogen) and puriﬁed under native con-
ditions as described previously [5]. Recombinant GST-cpSRP43 con-
structs were expressed from their corresponding pGex-4T-3
constructs in the strain BL21 and puriﬁed as described [4]. For SPR
experiments, the puriﬁed proteins were dialyzed against 10 mM
HEPES, pH 7.4, 5 mM MgCl2, and 150 mM NaCl (BIAcore buﬀer)
by using dialysis cassettes (Perbio) according to the manufacturer’s
manual. The dialyzed protein solution was concentrated by spinning
it in Vivaspin-columns at 4 C and 3000 · g. Aliquots were frozen in
liquid nitrogen and stored at 80 C.
2.3. SPR experiments using the BIAcore system
SPR experiments were carried out using the BIAcore 3000 system
equipped with a CM5 sensor chip covered with covalently bound
anti-GST antibodies. Experiments were carried out in 10 mM HEPES,
pH 7.4, 5 mM MgCl2, 150 mM NaCl and 0.005% Igepal. The
GSTcpSRP43 constructs or GST as a control were immobilized on
the sensor chip and recombinant cpSRP54M-his was passed over the
decorated chip in at least six various concentrations (cpSRP43: 20–
200 nM 54M; 43(255–376): 40–400 nM 54M; 43(227–376) and
43(227–320): 0.01–1 lM 54M). Data analysis was performed with Bia-
evaluation Software 3.0 as described before [15].
2.4. Yeast two-hybrid analysis
Yeast two-hybrid experiments were performed as described [5].2.5. Pulldown assay
Pulldown assays were performed as described [5], using 4 ll in vitro
translated, 35S-methionine labelled cpSRP54M and 1 lg of the indi-
cated recombinant GST-cpSRP43 constructs. As a control recombi-
nant GST (1.5 lg) was used.3. Results and discussion
3.1. Aﬃnities of the interactions between cpSRP43-constructs
and cpSRP54M
Recently, several studies were performed to deﬁne the
molecular details of the interaction between cpSRP54 and
cpSRP43. Results obtained mainly from yeast two-hybrid
experiments suggested that both C-terminal chromodomains
(CD2/3) are essential for the interaction with cpSRP54 by pro-
viding the binding interface for cpSRP54 [7]. However, these
experiments and in vitro binding experiments indicated that
the interaction between cpSRP54 and CD2/3 was signiﬁcantly
weaker than the interaction when full-length cpSRP43 was
used. Data from other groups conﬁrmed the ﬁnding that the
C-terminal region of cpSRP43 mediates the binding to
cpSRP54 [8]. However, results from in vitro binding assays
and isothermal titration calorimetry experiments demonstrated
that only CD2 is involved in binding to cpSRP54 [8,13]. In
addition, data obtained from quantitative pulldown experi-
ments using recombinant GST-cpSRP43 constructs indicated
that CD2 alone binds cpSRP54 as eﬃciently as full-length
cpSRP43 [8].
To analyse the binding and dissociation kinetics between
full-length cpSRP43 or various cpSRP43 constructs and
cpSRP54 quantitatively, SPR technology was utilized. For
interaction analysis, GST-cpSRP43, the indicated GST-
cpSRP43 constructs or GST as control were immobilized on
a sensor chip of a BIAcore3000 instrument via covalently
bound anti-GST antibodies. Various concentrations of recom-
binant cpSRP54M-his were passed over the decorated chip and
the equilibrium dissociation constants (KD) were calculated
from the association and dissociation rates (Table 1). The
KD value for the binding of full-length cpSRP43 and
cpSRP54M was estimated to be 2.5 nM, reﬂecting the high
aﬃnity of this interaction. A speciﬁc but signiﬁcantly weaker
binding of cpSRP54M to cpSRP43(255–376), encoding CD2/
3 and containing 15 additional N-terminal residues, was ob-
Table 2
Mutational analysis to study the role of the acidic residues of CD2 for
cpSRP54 binding
pACT2-constructs (prey) pGBKT7-54M (bait)
-his growth b-gal. activity
43 ++ ++
43(E271M) ++ ++
43(E274M) ++ ++
43(D276Y, E277M) ++ ++
43(E280M) ++ ++
43(D287A, E289M) ++ ++
43(D296A, D299A) ++ ++
43(E301M) ++ ++
43(E310M, D311A) ++ –
43(E310M) ++ ++
43(D311A) ++ ++
43(D315A) ++ ++
43(E317M, D318A) ++ ++
43(E321M) ++ ++
The indicated acidic residues of CD2 (location shown in Fig. 1) were
mutated and the interaction with cpSRP54M was analysed using the
yeast two-hybrid system. Therefore, yeast strain Y190 was cotrans-
formed with the combination of the indicated pACT2-43 construct and
pGBKT7-54M. Activation of the -his- and lacZ-reporter was measured
as described in Section 2.
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Fig. 2. CpSRP43 constructs containing mutations within the a-helix of
CD2 do not interact with cpSRP54. In vitro translated radiolabelled
cpSRP54M was incubated with recombinant GST-cpSRP43, the
indicated GST-cpSRP43 constructs or GST as a control. Proteins
were recovered by glutathione-Sepharose beads (upper panel). The
coomassie-stained recombinant GST-constructs used in the pull down
assays are shown in the lower panel. Experimental details are described
under Section 2.
Table 1
Dissociation constants for the interaction of cpSRP54M with GST-cpSRP43 constructs determined by SPR experiments
GST-construct kon (·105 M1 s1) kdiss (·103 s1) KD (nM)
cpSRP43 27.4a/10.3b 4.6a/3.3b 1.7/3.2
cpSRP43(255–376) 2.6 7.7 29.7
cpSRP43(227–376) 1.8 ± 0.2 9.0 ± 1.7 48.4 ± 14.0
cpSRP43(227–320) 1.4a/1.4b 6.8a/9.8b 48.8/70.1
The binding of the several GST-cpSRP43 constructs and cpSRP54M was analysed in a BIAcore3000 and KD values were calculated from
association and dissociation rate constants. In each experiment at least two selected concentrations were measured in triplicate. a,b indicate inde-
pendent sets of experiments, GST-cpSRP43(227–376) was analysed in three independent approaches (averaged values for kon and kdiss ± S.D.).
Experimental details are described in Section 2.
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interaction of the same construct lacking this N-terminal
extension and cpSRP54M was detected (data not shown). A
KD value in the same range as that for cpSRP43(255–376)
was detected for a construct that encodes the fourth ankyrin
repeat in addition to CD2/3 (cpSRP43(227–376)). Removal
of CD3 did not result in a signiﬁcant reduction in binding
aﬃnity indicating that it is not required for the formation of
the cpSRP54 binding site (Table 1). Taken together, our data
support the previously published data of Goforth et al. [8]
and Sivaraja et al. [13], that state that CD2 alone provides
the primary binding site for cpSRP54. However, the KD value
for this interaction with cpSRP54M was signiﬁcantly higher
than for full-length cpSRP43, suggesting that additional re-
gions of cpSRP43 are required to support the high aﬃnity
cpSRP complex formation. Nevertheless, further studies using
full-length proteins are necessary to support this notion and to
rule out structural alterations that might occur using deletion
constructs.
3.2. Analysis of the role of the acidic residues of CD2 for
cpSRP54 binding
Previously it was reported that a highly positively charged
segment in cpSRP54 (residues 530–539) constitutes the
cpSRP43 binding site [5]. It was demonstrated by mutational
analysis that arginine at position 537 is essential for binding
cpSRP43 and that mutation of arginine 536 drastically reduces
this interaction. Interestingly, analysis of the surface charge
distribution of the CDs of cpSRP43 revealed that the electro-
static potential of CD2 is highly negative, whereas those of
CD1 and CD3 are nearly zero or even positive [13]. These ﬁnd-
ings led to the speculation that electrostatic forces might drive
the interaction of cpSRP54 and cpSRP43. To test this assump-
tion we systematically converted all acidic residues within CD2
(location shown in Fig. 1) into neutral residues by site-directed
mutagenesis and analysed the eﬀect of these mutations on
binding to cpSRP54M using the yeast two-hybrid system. In
Table 2, it is shown that the generation of the double mutation
E310M/D311A in cpSRP43 led to a complete loss of binding
to cpSRP54M, whereas all other tested mutations were ineﬀec-
tive.
The ﬁnding that the construct cpSRP43(E310M,D311A) is
not able to interact with cpSRP54 was proven by two experi-
mental setups. In our ﬁrst approach, we veriﬁed by in vitro
pulldown experiments using GST-cpSRP43 or GST-
cpSRP43(E310M,D311A) that the mutation prevented bind-
ing to cpSRP54M (Fig. 2). In our second approach, the transit
complex formation with LHCP was assayed. The transit com-
plex consists of cpSRP and LHCP and represents a soluble
form of LHCP. In previous experiments, it was shown thatboth subunits, cpSRP43 and cpSRP54, must be present to
form a functional cpSRP, and are required to bind LHCP
[4,5]. Fig. 3 shows that the transit complex is not generated
in the presence of cpSRP43(E310M,D311A), proving the crit-
ical role of E310 and D311 for the constitution of functional
cpSRP.
Fig. 3. Transit complex formation is abolished in the presence of
cpSRP43 constructs containing mutations within the a-helix of CD2.
In vitro translated and radiolabelled pLHCP (3 ll) was either mixed
with 10 ll stromal extract (SE) (corresponding to 3 mg chlorophyll/ml)
or 4 ll in vitro translated cpSRP54M and the indicated recombinant
GST-cpSRP43 constructs (0.5 lg). The formation of the transit
complex was assayed on non-denaturing gels by radioimaging as
described [5].
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cpSRP43 using a pepscan of CD2
To analyse whether residues E310 and D311 are located in
a segment of cpSRP43 that mediates direct binding to
cpSRP54, or whether their mutation has structural conse-
quences, we mapped the interaction of CD2 with cpSRP54M
using an immobilized peptide library of CD2 (15-mer pep-
tides overlapping by 12 residues). The pepscan membrane
was incubated with recombinant cpSRP54M-his, and binding
of cpSRP54M-his was detected by immunodecoration with
anti-cpSRP54 antibodies. As a control, the same experiment
was performed with recombinant cpSRP54M(D536–540)-his,
a construct whose mutation within the cpSRP43-binding site
abolishes binding to cpSRP43 [5]. As shown in Fig. 4,
cpSRP54M interacts strongly with a single peptide compris-
ing residues 307–321. A weak signal was detected for the pep-
tide representing residues 280–294. The control experiment
using cpSRP54M(D536–540)-his generated no interaction sig-
nal. Interestingly, analysis of the NMR-structure of CD2 re-
vealed that the peptide 307-HVAEDVAKDYEDGLE-321
corresponds almost exactly to the a-helix of CD2 (residues
309–321). From these data and from the mutational analysis,
we concluded that the negatively charged C-terminal a-helix
of CD2 forms the minimal binding site for cpSRP54 and that
the region comprising residues 280–294 might contribute to
the overall binding.Fig. 4. Mapping the interaction of cpSRP54M and CD2 of cpSRP43 us
incubated with a peptide library (PepSpots, JPT Peptide Technologies, Berlin)
The peptide library contained 23 15-mer peptides, shifted by three residues.
cpSRP54M(D536–540)-his. As described previously, this construct contains
cpSRP43 [5]. Bound protein was detected by immunoanalysis using anti-cpSR
residues 280–294 of cpSRP43. Positions of the spots are indicated by numbThis result is in line with our previously published observa-
tion that a cpSRP43 construct lacking the a-helix of CD2
(cpSRP43(61–305)) is not able to bind cpSRP54 [7]. Likewise,
it was observed that a CD2 chimera wherein the a-helix was
replaced with that of CD3 could not interact with cpSRP54
[13].
In an attempt to analyse whether the presence of the a-helix
of CD2 in a CD is suﬃcient to enable binding to cpSRP54 we
generated a chimeric construct consisting of the b-sheet con-
taining N-terminal region of CD3 and the a-helix of CD2
and tested the interaction with cpSRP54M. However, we did
not detect interaction between this construct and cpSRP54M
(data not shown). These data suggest that both, the C-terminal
a-helix of CD2 and the right orientation within the CD, are
essential for cpSRP complex formation.3.4. Analysis of the role of hydrophobic residues of the
CD2-a-helix for cpSRP54 binding
In cpSRP54, the residues R536 and R537 were described to
be important for interaction with cpSRP43 [5]. Besides carry-
ing a positive charge, arginine side chains are also partially
hydrophobic (part of the side chain nearest to the protein
main chain), and are often described to be buried within a
hydrophobic core of a protein [16]. To analyse whether
hydrophobic residues within or close to the C-terminal a-he-
lix of CD2 are crucial for interaction with cpSRP54, we mu-
tated them individually and tested the interaction with
cpSRP54M. In Table 3, it is shown that the substitution of
V308 and V312 with glycine (V308G, V312G) led to a loss
of interaction with cpSRP54M, whereas the introduction of
the hydrophobic amino acid methionine at these positions
(V308M, V312M) and the mutations V306G and L320G
did not impair binding to cpSRP54M. These data indicate
that hydrophobic residues at positions 308 and 312 of CD2
are required for interaction with cpSRP54. In addition, we
observed no binding between the construct cpSRP43(A309M)
and cpSRP54M (Table 3 and see also Figs. 2 and 3). Since
this mutation does not alter in particular the hydrophobicity,
this observation suggests that a small residue might be re-
quired at this position.
Noticeably, all residues whose mutations abolish cpSRP54
binding are clustered close to the N-terminus of the C-terminal
helix (V308, A309, E310, D311, V312). This ﬁnding and the
observation that, in contrast to peptide 307–321, almost no
binding of cpSRP54M to peptide 310–324 was detected
(Fig. 4, spot 20), leads to the hypothesis that the N-terminaling a pepscan of CD2. Recombinant cpSRP54M-his (10 lg/ml) was
derived from a region of cpSRP43-containing CD2 (residues 253–333).
As a control, the pepscan membrane was incubated with recombinant
a deletion within the cpSRP43 binding site and cannot interact with
P54 antibodies. Spot 19 corresponds to residues 307–321 and spot 10 to
ers.
Table 3
Mutational analysis to study the role of hydrophobic residues of the
a-helix of CD2 for cpSRP54 binding
pACT2-constructs (prey) pGBKT7-54M (bait)
-his growth b-gal. activity
43 ++ ++
43(V306G) ++ ++
43(V308G) + –
43(V308M) ++ ++
43(A309M) + –
43(V312G) ++ –
43(V312M) ++ ++
43(A313M) ++ ++
43(L320G) ++ ++
Yeast strain Y190 was cotransformed with the combination of the
indicated pACT2-43 construct and pGBKT7-54M encoding the M
domain of cpSRP54. Activation of the -his- and lacZ-reporter was
measured as described in Section 2.
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cpSRP54. In addition, our data suggest that the negative
charge and the hydrophobic character of this region are re-
quired for interaction with cpSRP54M. However, currently it
cannot be excluded that the introduced mutations led to con-
formational changes in this region and further work is required
to get a detailed picture of the mechanisms underlying the
cpSRP complex formation.4. Conclusions
The structures of the second and third CD of cpSRP43
resemble those of typical CDs whose architecture consists of
a triple stranded b-sheet and a C-terminal a- helix [12,13]. De-
spite their conserved structural elements, CDs were found to
interact with their partners in various modes. For instance,
for a subclass of CDs, it was found that a hydrophobic ‘‘cage’’
consisting of several conserved aromatic residues of the b-sheet
region provides the binding pocket for methylated lysine resi-
dues [17–19], whereas the so called shadow CD of heterochro-
matin protein 1 (HP1) mediates its homodimerization and
interaction with its substrate peptide via its a-helix [20–22].
In this report, we propose that the C-terminal a-helix of
CD2 forms the essential binding site for cpSRP54. However,
CD2 alone binds cpSRP54 signiﬁcantly more weakly than
full-length cpSRP43, suggesting that other regions of cpSRP43
are possibly required to facilitate the high aﬃnity binding be-
tween cpSRP43 and cpSRP54. To get a more complete picture
of the structure of cpSRP and to analyse the conformational
changes of its subunits during complex formation, it will be
an interesting goal for the future to analyse the crystal struc-
ture of cpSRP and its individual components.
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